GSTM1 and ablepharon macrostomia syndrome: In contrast, the moderate/severe-AMS group experienced a notable increase of 7.1 g/L in Hb and 4.3% in HCT compared to the third day (P < 0.05; Figs. 1–3, and Table 2).